Navigation Links
Pivotal Trial Results for Motavizumab Published in Current Issue of 'Pediatrics'
Date:1/29/2010

GAITHERSBURG, Md., Jan. 29 /PRNewswire/ -- MedImmune today announced that clinical results of its pivotal multinational, randomized, double-masked trial for motavizumab have been published in the current issue of the peer-reviewed publication, Pediatrics: Official Journal of the American Academy of Pediatrics.  Motavizumab is an investigational monoclonal antibody (MAb) being evaluated by the FDA for its potential to prevent serious disease caused by respiratory syncytial virus (RSV) among infants at high risk.

The phase 3, pivotal trial assessed the safety and RSV hospitalization in 6,635 preterm infants aged six months or younger at enrollment or children aged 24 months or younger with chronic lung disease of prematurity who received either 15 mg/kg palivizumab or motavizumab monthly.  Secondary endpoints included outpatient medically attended lower respiratory tract infections (MALRIs), RSV-specific MALRIs, otitis media, antibiotic use, development of anti-motavizumab antibodies and motavizumab serum concentrations.

In this first head-to-head trial, motavizumab demonstrated non-inferiority, but not superiority, to Synagis® (palivizumab), meeting the primary endpoint with a 26 percent relative reduction in RSV hospitalizations versus Synagis (p<0.01 for non-inferiority) due to RSV. Motavizumab also demonstrated superiority compared to Synagis, with a 50 percent relative reduction in RSV lower respiratory tract infections requiring outpatient management (p=0.005), which was one of the secondary endpoints of the trial. Other secondary endpoints were not statistically significant. Adverse events were similar in both groups, although, motavizumab had two percentage points more adverse events reported for the skin compared to Synagis; the majority were non-specific rashes that did not recur or affect dosing.

In '/>"/>

SOURCE MedImmune
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
4. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
5. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
6. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
7. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
8. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
9. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
10. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
11. Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 17, 2014  ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE ... Trademark Office (USPTO) has issued a key patent ... immunotherapeutic vaccine targeting six tumor antigens that are ... Patent No. 8,871,211, which issued October 28, 2014, ... a dendritic cell composition comprising peptide epitopes of ...
(Date:12/17/2014)... Ga. and RALEIGH, N.C. ... Trial Marketing Communications, LLC (CTMC), and Integrated Clinical ... patient recruitment and retention for clinical trials announce ... Integrated Clinical Trial Marketing Services (i-CTMS). i-CTMS will ... retention services to pharmaceutical, biotechnology and medical device ...
(Date:12/15/2014)... , Dec. 12, 2014 Research and ... the addition of the "MEMS Gyroscopes Analog ... Analysis" report to their offering. ... gyroscopes for tactical grade applications made a lot ... term of reliability. They are now accepted in ...
Breaking Medicine Technology:ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 3MEMS Gyroscopes Analog Devices ADIS16136 Precision Angular Rate Sensor Reverse Costing Analysis 2
... Sciences, Inc. (OTCQB: RBCL), a provider of proprietary nutritional ... reported consolidated net sales of $28.4 million for the ... 2010 consolidated net sales of $28.2 million.  For the ... net loss of $71,000, or $0.00 per diluted share, ...
... March 19, 2012 Watson Pharmaceuticals, Inc. (NYSE: ... Laboratories, Inc. – Florida, filed an Abbreviated New Drug ... (FDA) seeking approval to market Niacin Extended-release Tablets, 500 ... versions of Abbott Laboratories, NIASPAN®. Abbott ...
Cached Medicine Technology:RBC Life Sciences Reports 2011 Results 2RBC Life Sciences Reports 2011 Results 3Watson Confirms NIASPAN(R) Patent Challenge 2
(Date:12/19/2014)... Randy Dotinga ... News) -- Common painkillers, including ibuprofen, might slightly reduce ... researchers say. Use of ibuprofen (Advil, Motrin) and ... cell skin cancer by 15 percent, the researchers concluded ... is usually caused by sun exposure. ...
(Date:12/17/2014)... While countless companies tempt patients to ... potential dangers of their purchase. Not only is the sale ... doctor, but patients who buy hCG online are typically receiving ... actually no real hCG present. Illegal internet hCG is typically ... safety standards and may contain unknown fillers that can pose ...
(Date:12/17/2014)... 2014 HeartMath® Inc., recognized as ... heart rate variability (HRV), heart coherence and the ... HRV databases and algorithms to chipset manufacturers and ... HeartMath’s partners to offer its HRV solutions, tap ... well as its normative HRV databases and algorithms ...
(Date:12/17/2014)... Now in its second year, the SeniorAdvisor.com ... best in senior living and home care across the ... and agencies that have received outstanding online feedback from ... 100,000 providers currently listed on SeniorAdvisor.com, only 879 were ... of 2015 Awards are located all over the country ...
(Date:12/17/2014)... 2014 (HealthDay News) -- Expectant parents should leave prenatal ... Administration recommends. Use of ultrasound imaging and heartbeat ... entirely risk-free, the agency warns. "Although there ... to ultrasound imaging and heartbeat monitors, prudent use of ... Shahram Vaezy, an FDA biomedical engineer, said in an ...
Breaking Medicine News(10 mins):Health News:Common Painkillers May Help Prevent Certain Skin Cancers, Study Finds 2Health News:Common Painkillers May Help Prevent Certain Skin Cancers, Study Finds 3Health News:Diet Doc Reveals the Real Dangers for Those who Buy hCG Online 2Health News:Diet Doc Reveals the Real Dangers for Those who Buy hCG Online 3Health News:HeartMath® Inc.’s HRV Platform Solutions Available for Licensing 2Health News:HeartMath® Inc.’s HRV Platform Solutions Available for Licensing 3Health News:The Inn at Willow Falls - Crest Hill, IL Wins 2015 Best of Assisted Living Award from SeniorAdvisor.com 2Health News:The Inn at Willow Falls - Crest Hill, IL Wins 2015 Best of Assisted Living Award from SeniorAdvisor.com 3Health News:FDA Warns Against Fetal 'Keepsake' Videos 2
... about his health care plan to SpineUniverse.com, whose recent survey results ... ... Montclair, NJ (PRWEB) October 31, 2008 -- Senator Barack ... care plan to SpineUniverse.com. Now every visitor to SpineUniverse.com -- ...
... The art and science of hormone,balancing vs. hormone replacement ... believe that breast cancer and its risks can be ... the landmark book, "What Your Doctor May Not Tell ... Your Life", nearly all risk,factors associated with breast cancer ...
... cancer related to HBV viral infection in Asian countries, ... treated by surgical resection including liver transplantation and non-surgical ... lung, so called lung metastasis from liver cancer is ... are very advanced and too late in being adequately ...
... for a Healthy Pet(R), contest sponsored by Morris,Animal ... DENVER, Oct. 31 Veterinarians provide our pets ... healthy and happy lives. To,recognize their efforts, hundreds ... "Thank Your Vet for a Healthy Pet(R)" contest, ...
... 31 A new report shows many are ... Here,s more on ways to get the,most out ... staying healthy., Listen to this report ... can access video, audio, text, graphics and,photos for ...
... WASHINGTON, Oct. 31 In the final 72-hours ... other volunteers,across the country are joining 4,000 SEIU ... off the job to bring home victory for,Barack ... change working,families need., SEIU,s major GOTV operations ...
Cached Medicine News:Health News:Senator Obama Explains His Health Care Plan to SpineUniverse.com 2Health News:Senator Obama Explains His Health Care Plan to SpineUniverse.com 3Health News:Natural Hormone Balance: Gaining Ground in the Fight Against Breast Cancer 2Health News:If metastasectomy should be performed before other treatments 2Health News:Hundreds of Pet Owners Nominate Veterinarians in Nationwide Contest to Find America's Best Vet 2Health News:Hundreds of Pet Owners Nominate Veterinarians in Nationwide Contest to Find America's Best Vet 3Health News:In Final 72-Hour Push, SEIU Members Get Out The Vote for Barack Obama and Other Working Family Candidates Across the Country 2
Low-profile, hand-held instrument....
Low-profile, hand-held instrument....
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries....
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries....
Medicine Products: